System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Johannes A Langendijk is an expert in Radiotherapy at University Medical Center Groningen (Netherlands). As of October 2026, ScienceLeadR ranks Johannes A Langendijk in the top 1% of experts worldwide for Pharyngeal Diseases, Otorhinolaryngologic Neoplasms and Esophageal Diseases. Johannes A Langendijk has authored 1,019 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 1 of them ongoing. SLR score: 2,794 (community average: 125). How the SLR is computed.

LeadR Profile

Johannes A Langendijk University Medical Center Groningen Netherlands
2 794 ScienceLeadR Reputation 2794

Unlock

Register Login
Network Map

Radiotherapy

Subspecialties: Oncology - Medical Imaging - Nuclear Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1997 - 2026
Source: PubMed

Amsterdam University Medical Center

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1019

Citations

Citations: 30 161 1st author: 37 Last author: 186 Unique author: 5

Main journals

Radiother Oncol 462
Int J Radiat Oncol Biol Phys 122
Oral Oncol 33
Head Neck 30
Med Phys 26

Best Journals

Lancet Oncol 6
Cancer Cell 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.
PMID 42933448 — neoplasms, nasopharyngeal carcinoma, therapeutics		Lancet Oncol Top journal20260
Predicting taste alteration in head and neck cancer patients using 3D transformer-based deep learning model.
PMID 42906280 — radiotherapy, neoplasms, deep learning, head and neck neoplasms, therapeutics, learning, taste		Oral Oncol20260
Dose-related cardiac side effects and its impact on survival following thoracic radiotherapy: A scoping review.
PMID 42898116 — radiotherapy, lung, heart, cardiotoxicity		Clin Transl Radiat Oncol20260
Applying a pretrained DL-based IMPT planning workflow in an external center: A feasibility study in oropharyngeal cancer.
PMID 42744075 — oropharyngeal neoplasms, radiotherapy, feasibility studies, workflow, neoplasms, deep learning, learning		Radiother Oncol20260
Evaluating imputation methods for longitudinal clinical trajectories: Toxicities in head and neck cancer treatment.
PMID 42858855 — radiotherapy, neoplasms, head and neck neoplasms, therapeutics		Radiother Oncol20260

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 7
Phase 3 4
Phase 1 1

By status:

Completed 5
Recruiting 3
Active not recruiting 2
Terminated 1
Unknown 1

By type:

Interventional 7
Observational 5

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 2
multicentric5to9 3
multicentricup10 3

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Prediction Models for Complications After CRT in Esophageal Cancer
NCT06366828 — neoplasms, esophageal neoplasms		N/ARecruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS